Thinking of joining a study?

Register your interest

Become a volunteer?

NCT03450876 | COMPLETED | Melanoma

Long Term Quality of Life in Melanoma Patients in Netherlands
Sponsor:

Bristol-Myers Squibb

Brief Summary:

Study of late physical, psychological and social effects in patients treated with ipilimumab for advanced (stage IV or unresectable stage III) melanoma.

Condition or disease

Melanoma

Intervention/treatment

Non-Interventional

Study Type : OBSERVATIONAL
Estimated Enrollment : 89 participants
Official Title : A Prospective Multicenter Cohort Study of Late Physical Psychological and Social Effects in Patients Treated With Ipilimumab for Advanced Melanoma
Actual Study Start Date : 2016-12-15
Estimated Primary Completion Date : 2020-06-17
Estimated Study Completion Date : 2020-06-17

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: 1
Criteria
Inclusion Criteria-
  • * Patient population: Adults ≥ 18 years of age at diagnosis, diagnosed with histologically confirmed advanced (stage IV or unresectable stage III) melanoma, who have received at least one course of ipilimumab treatment (first, second, or second plus line; routine practice or study treatment) in one of the specified treatment centers, and who have survived at least 2 years after (completion of) ipilimumab treatment (measured from last ipilimumab administration)
  • * Matched healthy control population: Individuals without melanoma (stage III or IV) diagnosis that have been included in the PROFILES cohort
    • Exclusion Criteria
  • * Insufficient understanding of the Dutch language
  • * Other anticancer treatment after ipilimumab or during study entry
  • * Disease recurrence during the study
  • Other protocol defined inclusion/exclusion criteria could apply
    • Long Term Quality of Life in Melanoma Patients in Netherlands

    Location Details

    NCT03450876

    Please Choose a site

    How to Participate

    Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

    Locations

    Not yet recruiting

    Netherlands,

    Local Institution

    Amsterdam, Netherlands, 1066 CX